These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 29679919

  • 1. The effect of growth hormone on bioactive IGF in overweight/obese women.
    Dichtel LE, Bjerre M, Schorr M, Bredella MA, Gerweck AV, Russell BM, Frystyk J, Miller KK.
    Growth Horm IGF Res; 2018 Jun; 40():20-27. PubMed ID: 29679919
    [Abstract] [Full Text] [Related]

  • 2. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 May; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 4. Bioactive insulin-like growth factor-I in obesity.
    Frystyk J, Brick DJ, Gerweck AV, Utz AL, Miller KK.
    J Clin Endocrinol Metab; 2009 Aug; 94(8):3093-7. PubMed ID: 19470623
    [Abstract] [Full Text] [Related]

  • 5. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
    Gill MS, Toogood AA, Jones J, Clayton PE, Shalet SM.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
    [Abstract] [Full Text] [Related]

  • 6. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG, Ropelato MG, Domené HM, Pennisi P, Heinrich JJ, Jasper HG.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [Abstract] [Full Text] [Related]

  • 7. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
    De Marinis L, Mancini A, Valle D, Bianchi A, De Luca AM, Fulghesu AM, Villa P, Mancuso S, Lanzone A.
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
    [Abstract] [Full Text] [Related]

  • 8. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [Abstract] [Full Text] [Related]

  • 9. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
    Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S.
    J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
    [Abstract] [Full Text] [Related]

  • 10. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 11. No influence of prednisolone on IGFBP-3 proteolysis in healthy young men.
    Dall R, Wolthers T, Flyvbjerg A, Grøfte T, Sandahl Christiansen J, Jørgensen JO.
    Horm Res; 2001 Sep; 55(2):95-101. PubMed ID: 11509866
    [Abstract] [Full Text] [Related]

  • 12. Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects.
    Rasmussen MH, Juul A, Kjems LL, Hilsted J.
    Eur J Endocrinol; 2006 Oct; 155(4):575-81. PubMed ID: 16990657
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D, Tacchino RM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 15. Increases in Bioactive IGF do not Parallel Increases in Total IGF-I During Growth Hormone Treatment of Children Born SGA.
    Wegmann MG, Jensen RB, Thankamony A, Frystyk J, Roche E, Hoey H, Kirk J, Shaikh G, Ivarsson SA, Söder O, Dunger DB, Juul A.
    J Clin Endocrinol Metab; 2020 Apr 01; 105(4):. PubMed ID: 31665326
    [Abstract] [Full Text] [Related]

  • 16. Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.
    Utz AL, Yamamoto A, Sluss P, Breu J, Miller KK.
    J Clin Endocrinol Metab; 2008 Oct 01; 93(10):4033-40. PubMed ID: 18647804
    [Abstract] [Full Text] [Related]

  • 17. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan 01; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 18. Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH.
    Kicman AT, Miell JP, Teale JD, Powrie J, Wood PJ, Laidler P, Milligan PJ, Cowan DA.
    Clin Endocrinol (Oxf); 1997 Jul 01; 47(1):43-50. PubMed ID: 9302371
    [Abstract] [Full Text] [Related]

  • 19. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
    Yuen KC, Cook DM, Rumbaugh EE, Cook MB, Dunger DB.
    Horm Res; 2006 Jul 01; 65(1):6-13. PubMed ID: 16340214
    [Abstract] [Full Text] [Related]

  • 20. Relationship between serum leptin and the insulin-like growth factor-I system in humans.
    Grégoire Nyomba BL, Johnson M, Berard L, Murphy LJ.
    Metabolism; 1999 Jul 01; 48(7):840-4. PubMed ID: 10421222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.